Skip to main content
Current Neuropharmacology logoLink to Current Neuropharmacology
. 2012 Dec;10(4):344–353. doi: 10.2174/157015912804143496

Oxidative Stress in the Hypothalamus: the Importance of Calcium Signaling and Mitochondrial ROS in Body Weight Regulation

Erika Gyengesi 1,*, George Paxinos 1,2, Zane B Andrews 3
PMCID: PMC3520044  PMID: 23730258

Abstract

A considerable amount of evidence shows that reactive oxygen species (ROS) in the mammalian brain are directly responsible for cell and tissue function and dysfunction. Excessive reactive oxygen species contribute to various conditions including inflammation, diabetes mellitus, neurodegenerative diseases, tumor formation, and mental disorders such as depression. Increased intracellular calcium levels have toxic roles leading to cell death. However, the exact connection between reactive oxygen production and high calcium stress is not yet fully understood. In this review, we focus on the role of reactive oxygen species and calcium stress in hypothalamic arcuate neurons controlling feeding. We revisit the role of NPY and POMC neurons in the regulation of appetite and energy homeostasis, and consider how ROS and intracellular calcium levels affect these neurons. These novel insights give a new direction to research on hypothalamic mechanisms regulating energy homeostasis and may offer novel treatment strategies for obesity and type-2 diabetes.

Keywords: Oxidative stress, Reactive oxygen species, NPY, AgRP, POMC, Ghrelin, Leptin, Mitochondrial respiration, Hypothalamic appetite control.

INTRODUCTION

The hypothalamus is a critical region that regulates appetite, body weight and glucose homeostasis. Due to its anatomical localization, it is in a position to directly sense and integrate metabolic information from the periphery and then dictate neural output commands to the corresponding tissues and organs, accordingly. Within the hypothalamus there are several important nuclei regulating appetite and body weight, including the lateral hypothalamic area (LH), the paraventricular (Pa), the dorsomedial (DM), the ventromedial (VMH), and the arcuate hypothalamic nuclei (Arc). Among these areas, the Arc has received most attention and its role in appetite control is fairly well described and defined. In appetite and body weight control, two populations of hypothalamic neurons within in the Arc have mutually antagonistic functions [1]. Activation of neuropeptide-Y (NPY)/agouti-related protein (AgRP) containing neurons results in increased food intake, while the activation of pro-opiomelanocortin (POMC) neurons suppresses appetite [2, 3]. In the Arc, almost all POMC containing neurons also contain cocaine-and-amphetamine responsive transcript (CART), which serves as an anatomical marker and functions as an anorexigenic signal molecule [4, 5]. Within POMC neurons, α-MSH is the critical anorexigenic peptide produced by posttranslational processing of POMC. Both the AgRP/NPY- and POMC/CART - containing neurons contain gamma amino butyric acid (GABA) as their main neurotransmitter [6-9] and project to strongly overlapping areas, including the Pa and the LH and DM [10-12]. POMC neurons contain GABA or glutamate [13, 14], however the precise role of GABA or glutamate transmission from POMC neurons on feeding circuits remains unclear. In their recent and detailed experiments, Dicken et al., (2012) elegantly showed that besides the slow and long lasting synaptic actions typical in the case of neuropeptides, POMC neurons are also rapidly regulate both their own activity via auto regulation and the activity of downstream neurons [13, 15]. However, recent optogenetic experiments do not support an autoregulatory role of POMC within the Arc [15].

Eukaryotic cells under normal conditions have the ability to regulate the production of reactive oxygen and nitrogen species (ROS/RNS) by controlling the balance between the reduction and oxidation (redox) processes. ROS are chemically reactive molecules and free radicals that contain oxygen, such as peroxides derived from molecular oxygen [16]. At low cellular levels ROS/RNS act as signaling molecules, however at higher concentrations ROS/RNS react with lipids, proteins, DNA/RNA and cause cellular damage to organelles, particularly mitochondria [17]. An imbalance in redox processes causes the build up of ROS/RNS, which eventually contributes to cell damage. Increased levels of ROS/RNS are directly linked to neurodegenerative diseases, such as Alzheimer’s diseases, Parkinson’s diseases, and other diseases like schizophrenia, bipolar disorder, myocardial infarction, and neuropathy in type-2 diabetes mellitus [18-20]. Many antioxidative enzymes and processes in mitochondria and cytoplasm regulate the amount of ROS/RNS produced in cells [21] and act to balance the redox process. Antioxidants remove ROS/RNS by scavenging radicals, decreasing their production, thus preventing oxidative damage. Such scavenger antioxidants are coenzyme Q10, vitamin C and E, and glutathione. Antioxidant enzymes, such as superoxide dismutase (SOD), glutathione peroxidase (GPX) and catalase neutralize ROS including peroxides and superoxide. Some proteins also function as antioxidants by binding ROS/RNS, e.g. acute phase proteins such as albumin, transferrin, haptoglobin and ceruloplasmin [22]. These antioxidant systems protect against the deleterious actions of increased ROS/RNS molecules.

Oxidative stress in neurons increases intracellular Ca2+, increases lipid peroxidation, and releases excitatory amino acids from presynaptic buttons (such as glutamate). The role of Ca2+ in cytotoxicity is well known, however the exact mechanisms are still to be clarified [23, 24]. The maintenance of the intracellular Ca2+ homeostasis is strongly dependent on precise temporal and spatial control of Ca2+-ATPase activity in the plasma membrane, Ca2+ uptake into the intracellular stores and the effectiveness of calcium binding proteins (CBPs) in the cytosol [25-27]. These mechanisms are critical, as a shift in the intracellular cation levels, in particular excessive Ca2+ accumulation, induces oxidative stress [28].

Moreover, extra and intracellular Ca2+ ion concentrations affect the Ca2+-ATPase activity, the tricaboxylic acid cycle and oxidative phosphorylation. When stimulated mitochondria consume more oxygen, which in turn results in more ROS production. Voltage-gated Ca2+ channels are expressed throughout the entire hypothalamus, contributing to the increased cytoplasmic Ca2+ levels in sensitive neurons [29]. Alteration of voltage-gated Ca2+ channels by ROS can lead to cell death by apoptosis or excitotoxicity [30]. It is well known that Ca2+ entering the cells leads to elevated oxidative stress in the mitochondria, however the connection has not been thoroughly examined yet.

This review examines the role of ROS in NPY/AgRP and POMC neurons in hypothalamic processes that regulate energy and glucose metabolism. The accumulated evidence listed below illustrates that ROS play an important physiological role in hypothalamic neurons controlling energy metabolism and glucose homeostasis. In addition, increased intracellular Ca2+ level is likely a contributing factor to increase ROS production in these neurons.

HYPOTHALAMIC ROS REGULATES GLUCOSE AND FATTY ACID SENSING

In recent years, abundant research demonstrates that elevated ROS production causes cellular dysfunction and death, whereas normal ROS levels produced in mitochondria are required as a vital physiological sensor for hypothalamic glucose and fatty acid sensing [31, 32]. The ability of hypothalamic neurons to sense glucose is crucial to maintain body weight and control obesity [33]. Glucose sensing at the cellular level in the Arc is cell-type specific. While POMC neurons utilize glucose as their main fuel, NPY/AgRP neurons are inhibited by high glucose level and may use free fatty acids as their main metabolite [34-36]. Negative energy balance, for example during fasting, is characterized by hypoglycemia and activates NPY/AgRP neuronal firing rate. Interestingly, ROS production during this phase is not significantly increased [34]. On the contrary, POMC neurons are more active in response to feeding or during positive energy balance and use glucose as their main fuel. Under normal chow fed conditions POMC neurons produce significantly more ROS compared to NPY/AgRP neurons [34], implying that metabolic status differentially regulates ROS production in these neurons. Indeed, ROS production needs to be buffered to maintain homeostasis, however the nature of this ROS buffering system in POMC or NPY/AgRP neurons remains unknown. Because these neurons respond differently to positive or negative energy balance, it is likely that NPY/AgRP and POMC neurons possess either 1) unique molecular machinery and/or 2) unique upstream sensing mechanisms that activate cellular ROS buffering systems.

The cellular pathways through which Ca2+ increases ROS production during glycolysis has been examined by Hernandez-Fonseca et al., (2008) in hippocampal primary neuronal cell cultures. Their results confirmed that hypoglycemia associates with increased ROS production and excitotoxicity. Further, Ca2+ influx through N-Methyl-D-aspartate (NMDA) receptors, which is one of the ionotropic glutamate receptors, plays a crucial role in ROS production during moderate energy depletion [37]. NPY/AgRP neurons are located close to the median eminence and capable of sensing nutrient and hormone concentrations in the blood. Kuo et al., (2011) recently examined how redox signaling via ROS contributes to nutrient sensing and appetite regulation [38]. In the same study, they investigated the effects of phenylpropanolamine (PPA), an appetite-suppressing sympathomimetic agent, on both NPY and POMC neurons. PPA induces initial weight loss during a 4-day treatment period in rats. This anorexigenic effect is mediated by catecholamine release that has an inhibitory effect on hypothalamic NPY neurons [39]. In the same study, they found that the PPA not only suppresses appetite but also increases endogenous antioxidants, such as SOD and glutathione S-transferase [38] and increases POMC expression. At the same time, PPA reduces NPY expression, which collectively results in decreased food intake and weight loss. Their findings confirmed that ROS plays a role in appetite control by anticipating in both lipid and glucose sensing [40, 41].

Protein kinase C (PKC) is a common intracellular signaling protein that is particularly sensitive to redox state changes. PKC- λ is a Ca2+ independent, but triacylglycerol dependent, atypical PKC isoform. Kuo et al., (2011) showed that PKC- λ mediated the appetite-suppressing effect of PPA by increasing oxidative stress. The increased ROS production stimulated POMC activity and inhibited NPY activity [42]. These results also indicate that ROS-induced signaling mechanisms are more sensitive in POMC neurons.

Benani et al., (2007) showed that increased levels of plasma triglyceride, which is an endocrine marker of positive energy balance, resulted in local and rapid production of ROS in the brain. In parallel, increased mitochondrial O2 consumption also triggered ROS production. The authors found that the elevated hypothalamic ROS modified the redox state of oxidized and reduced glutathione but failed to cause oxidative stress measured by dichlorofluorescein fluorescence ex vivo. These authors concluded that acute hypertriglyceridemia triggered hypothalamic ROS production due to the increased mitochondrial activity [32].

These findings support the notion that ROS levels influence NPY/AgRP and POMC neuronal function. Redox signals and ROS respond to metabolic signals and influence the ability of NPY/AgRP or POMC neurons to sense fuel availability, regulate food intake and body weight.

MITOCHONDRIAL RESPIRATION AND OXIDATIVE STRESS IN THE HYPOTHALAMUS

Mitochondrial dysfunctional causes oxidative stress, as mitochondria generate, and are targeted by, ROS. During normal cellular respiration, O2 is reduced to H2O in mitochondria by oxidative phosphorylation, which produces energy in the form of ATP for cell function. During these reactions, electrons travel through the mitochondrial electron transfer chain (ETC) that includes complex I (NADH uniquinone oxireductase), complex II (succinate ubiquinone oxireductase), complex III (ubuquinone-cytochrome c oxidase), complex IV (cytochrome c oxidase), complex V (ATP synthase), as well as ubiquinone and cytochrome c. The complexes I to IV work to establish a H+ gradient across the inner membrane of the mitochondria that creates the electrochemical energy gradient to drive complex V to synthetize ATP. The reduction of O2 to H2O produces several ROS molecules, including H2O2, O2- and OH●. Complex I and III produce ROS in the highest capacity [43, 44]. Besides the ETC, the NADPH oxidase and ATPase are also an alternative source of O2- in the central nervous system.

The role of complex I in both anorexia nervosa and hypothalamic degeneration was further examined by Lindfors et al., (2011) taking advantage of the anx/anx mouse model. They provided evidence for the mitochondrial dysfunction in the hypothalamus by measuring mitochondrial respiration and detected significant reduction in complex I-driven respiration, while complexes II-V remained intact [45]. The authors hypothesized that the symptoms of anorexia could be related to defective mitochondrial oxidative phosphorylation at complex I [46]. Complex I deficiency arises from mutations in nuclear DNA-encoded subunits and complex I is a major contributor to ROS production. Therefore, defective complex 1 activity in anx/anx mice presumably leads to increased hypothalamic ROS production, which may have a direct effect on hypothalamic circuits regulating satiety, resulting in a chronic state of anorexia. This hypothesis, however, remains to be tested.

Only recently, studies have begun to explore the role of ROS specifically in the NPY/AgRP and POMC/CART neurons. Diano et al., (2011) revealed that a decrease in ROS production reduces POMC cell activation and increases NPY/AgRP cell activation, which in turn promotes feeding. These results highlight that sufficient ROS production is required to maintain POMC neuronal function and to reduce feeding, which is consistent with studies by Kuo et al., (2012) presented above. This study also showed that ROS scavenger treatment increased c-fos expression in NPY/AgRP neurons and an elevated food intake in normal mice. ROS scavenger treatment also lowered c-fos expression and initiated a significantly higher peroxisome number formation in POMC neurons of diet-induced obese mice, indicating that ROS activates POMC neurons [47]. High fat diet caused peroxisome proliferation and decreased ROS levels in POMC neurons and promoted food intake. On the contrary, suppressed peroxisome proliferation increased ROS levels in POMC neurons. Direct application of ROS into the central nervous system increased POMC neuronal activity and decreased food intake in diet-induced obese mice. These findings suggest that ROS plays an important regulatory role in POMC neuronal function to maintain energy homeostasis. Positive energy balance, which is characterized by hyperglycemia and glycolytic metabolism, activates POMC neurons and generates significant ROS that acts as an endogenous intracellular feedback signal in POMC neurons to control activity. Consistent with this idea, hyperglycemia induces mitochondrial ROS production [48]. In negative energy balance, NPY/AgRP neurons respond to the low levels of glucose and increase neuronal firing rate [49] and potentially use fatty acids as fuel to sustain this firing. Increased neuronal activity is followed by Ca2+ influx, which elevates ROS production in neurons [37]. However, NPY/AgRP neurons do not produce and release considerable amount of ROS. These results indicate that NPY/AgRP neurons have unique cellular properties that rapidly and efficiently buffer ROS production or a mechanism that restricts ROS production.

Ghrelin and leptin are two major hormonal regulators of appetite and energy homeostasis. Ghrelin is a gut-derived hormone that increases NPY/AgRP activity in the Arc and increases food intake [34]. Ghrelin activates AMP-activated protein kinase (AMPK) in NPY neurons, which inhibits acetyl choline-A carboxylase and fatty acid synthase, and importantly increases mitochondrial respiration and ROS production [50, 51]. Ghrelin increased hypothalamic mitochondrial respiration via uncoupling proteins (UCP2), which in turn reduces ROS production and scavenges free radicals, as ghrelin elevated synaptosomal ROS production UCP2 knockout mice, but not in their wild-type counterparts. In situ ROS levels detected by dihydroethidium bromide showed that UCP2 buffers ghrelin-induced ROS production in identified NPY neurons, whereas ghrelin did not affect POMC ROS production [34]. The ROS buffering properties of UCP2 allows ghrelin to sustain NPY/AgRP neuronal activity under conditions of negative energy balance. Interestingly, baseline ROS levels in POMC neurons are higher than NPY/AgRP neurons, suggesting POMC neurons may be more vulnerable to free radical-induced degeneration. Uncoupling proteins have the capacity to reduce ATP and ROS production by promoting fatty acid oxidation and increase mitochondrial biogenesis, hence they also play a role in the rate of aging and life span [52, 53].

The adipose tissue derived hormone leptin plays a central role in the regulation of energy homeostasis. Leptin acts via the long form of the leptin receptor (LepRb) that is expressed on both NPY/AgRP and POMC/CART neurons in the hypothalamus, mostly in the ventral premamillary (PMV), the DM and Arc nucleus and modulates the activity of both NPY/AgRP and POMC neurons [54]. Whether or not leptin influences ROS production to maintain POMC neuronal function remains to be determined. It is known that leptin depolarizes POMC neurons, however the exact description of the ion channels and currents involved remains to be determined. Using whole cell recording in POMC-EGFP transgenic mice, Qiu et al., (2010) found that transient receptor potential (TRCP) channel blockers inhibited the leptin-induced depolarization in POMC neurons, while lanthanum (La3+) and intracellular Ca2+ potentiated the effect of leptin [55]. Under physiological conditions, extracellular Na+ activates a nonspecific cation current and increases intracellular Ca2+ levels [56].

ROLE OF CALCIUM/CALCIUM BINDING PROTEINS IN THE HYPOTHALAMUS

The maintenance of the intracellular Ca2+ homeostasis depends on the precise temporal and spatial control of Ca2+-ATPases activity in the plasma membrane, Ca2+ uptake into the intracellular stores, influx through voltage-operated and receptor-operated channels, release from intracellular compartments and the effectiveness of Ca2+ buffering via CBPs in the cytosol and the plasma membrane [25-27, 57, 58]. Excessive intracellular Ca2+ accumulation causes mitochondrial ROS production and significantly elevates oxidative stress within cells [28]. Neuronal Ca2+ is stored either in the endoplasmatic reticulum (ER) or in mitochondria and both organelles contain very high Ca2+ concentrations. Ca2+ entry into the mitochondria matrix depolarizes the mitochondrial membrane potential and reduces ATP synthesis [59]. Indeed, excessive Ca2+release from these storage organelles indicate cellular damage that eventually leads to cell death [60]. There is also evidence that ROS produced by the mitochondria are directly involved in cell death [61].

Ca2+ is a key signaling molecule involved in regulating food intake, body weight and glucose homeostasis. Recently neuronal over-expression of the Ca2+/calmodulin dependent protein kinase (CaMKK) was shown to protect mice from high fat diet-induced weight gain, insulin resistance and glucose homeostasis. CaMKK is activated by the change of the intracellular Ca2+ [62-64] and acts as an upstream activator of AMPK, independent of AMP levels. In hypothalamic neurons, CaMKK regulates orexigenic NPY production [65, 66]. Ghrelin activates the ghrelin receptor (GHSR), a seven transmembrane G-coupled protein linked to Gq and activation of these receptors on Arc NPY neurons increases intracellular Ca2+ levels and activates CamKK [67]. Activated CaMKK stimulates AMPK pathways, that results in increased ATP generation and fatty acid oxidation, which leads directly to increased ROS production in the cells [68, 69].

Ca2+ plays an important, albeit underappreciated, role in appetite regulation and energy homeostasis through central and peripheral effects. Further study is required to elucidate the role of Ca2+ in defined neuronal populations important for appetite regulation such as NPY/AgRP and POMC. Indeed, CBPs are important regulators of intracellular Ca2+ concentrations and hence it is crucial to investigate their role in regulating Ca2+ levels in certain neuron populations.

CALCIUM BINDING PROTEINS IN THE HYPO-THALAMUS

The intracellular Ca2+ concentration is approximately 20,000-fold lower than extracellular Ca2+, indicating the precise cellular control of cytoplasmic Ca2+ levels [70]. Indeed, the resting intracellular cytosolic Ca2+ concentration is around 100nM, which can increase up to 1-2 μM in response to various stimuli in the Arc nucleus [71, 72]. This clearly necessitates efficient and rapid intracellular Ca2+ buffering and CBPs represent one such buffering system. CBPs sense and bind to Ca2+ ions to maintain intracellular Ca2+ homeostasis. Although present in various hypothalamic nuclei, their functional role has not been clarified. Here we describe the hypothalamic expression of CBPs and discuss the functional implication of CBPs on Ca2+-induced ROS production and energy metabolism.

Parvalbumin (Pv) is expressed in the ventrolateral tuberal hypothalamus (PV1 nucleus) in rats and mice [73, 74]. However, little is known about the function of these neurons. Interestingly, unlike most Pv containing neurons in the brain that express GABA, these neurons contain the excitatory neurotransmitter glutamate [74]. Glutamate increases ROS production with or without extracellular Ca2+ [75]. The activation of ionotropic glutamate receptors leads to Ca2+ influx into the cell from the extracellular space, resulting in increased Ca2+ level [76]. In addition, activation of the metabotropic glutamate receptors also leads to Ca2+ release from intracellular stores [77]. These studies highlight that cells with glutamate neurotransmission require efficient Ca2+ buffering properties, such as CBPs. Besides the PV1 nucleus in the hypothalamus, the Arc expresses Pv containing neurons, which show a 10-fold increase in response to estrogen in female mice [78].

Secretagogin (Scgn) is a recently described CBP cloned from pancreatic (-cells and endocrine cells of the gastrointestinal tract [79]. Scgn is a member of the EF-hand family of CBPs containing 3D –motif to bind Ca2+ in the cytosol. It is widely expressed in the rodent, primate and human brain, serving as a useful marker for areas in the telencephalon, such as the olfactory bulb, the hippocampus, amygdaloid complex, the basal forebrain and the hypothalamus [80-82]. Within the hypothalamus, Scgn-containing neurons are located in the Arc, the periventricular nucleus, the Pa, and the DMH. In the Arc, we found that approximately 50% of the NPY-AgRP neurons contain Scgn (Gyengesi, unpublished). We also found that Scgn is not co-expressed with POMC in the hypothalamus. These findings indicate that Scgn expression might play an important role in appetite by buffering intracellular Ca2+ in NPY, but not POMC neurons, during negative energy balance. Indeed, ghrelin levels increase during negative energy balance and stimulate feeding behavior by increasing intracellular cytosolic Ca2+ concentration, CaMKK and AMPK in NPY but not POMC neurons [6, 51, 83]. Thus, there is a direct requirement to buffer Ca2+ in NPY but not POMC neurons to maintain cellular firing during negative energy balance. Moreover, NPY/AgRP neurons generate less ROS production compared to POMC neurons [34]. Because buffering intracellular Ca2+ controls ROS production, the lack of Scgn and other CBPs in POMC neurons might contribute to elevated ROS compared to NPY/AgRP.

Calretinin-positive perikarya and neuropil were noticed in the ventral and dorsal portions of the suprachiasmiatic nucleus (SCh), lacking immunoreactivity in the central core of the SCh of the common marmoset [84]. Calretinin immunoreactivity was low in the neonatal SCh and increased with development in the ventrolateral SCh [85].

While it is one of the most commonly distributed CBP in the brain, little is known about the expression pattern and functional role of calbindin D28k (Cb) in the hypothalamic feeding circuit in mice. Based on the Chemoarchitectonic Atlas of the Mouse Brain by Watson and Paxinos, Cb is expressed in the cell bodies of the Pa, DMH, Arc, periventricular and VMH, together with strong neuropil [86].

SIGNALING MOLECULES AND PATHWAYS IN CONNECTION WITH CA2+ AND ROS

AMPK is a serine/threonine protein kinase that senses nutrients and hormones in the hypothalamus [87]. It plays a key role in general growth and metabolism of the cells. Deleting the catalytic subunit (ampkα2) from POMC neurons causes obesity and impaired glucose sensing [88, 89]. CaMKK-β is an upstream regulator of AMPK, which is also involved in the regulation of energy homeostasis [65]. CaMKK-β activates AMPK depending on intracellular Ca2+ levels and initiates energy producing mechanisms to restore ATP levels. To further examine the role of CaMKK in the hypothalamic control of appetite, Anderson et al., generated neuron specific CaMKK deletions [65]. Deletion of CaMKK-β in NPY/AgRP neurons reduced food intake and body weight, while deleting CaMKK-β in POMC neurons did not affect energy homeostasis or glucose metabolism [65, 89, 90]. Racioppi et al., (2012) recently described that genetic ablation of CaMKK2 protected mice from diet-induced obesity, insulin resistance and glucose intolerance. CaMKK2 prevented high fat diet-induced glucose intolerance by attenuating the inflammatory response in adipose [65, 91]. CaMKK2 is responsible for regulating the amplitude of the macrophage inflammatory response, which is induced by excess nutrient or pathogens [91].

A recent study described a presynaptic mechanism involving Ca2+ release that maintains NPY/AgRP neuronal firing [49]. Yang et al., (2011) showed that food deprivation increases the number of excitatory inputs on NPY/AgRP neurons that resulted in increased NPY/AgRP activity, which in turn stimulated feeding behavior. Ghrelin increased a presynaptic signaling pathway that induced direct Ca2+ release from internal stores via the ryanodine receptor. This activated presynaptic AMPK in nerve terminals synapsing onto NPY/AgRP neurons and maintained elevated NPY/AgRP action [49]. Kohno et al., (2011) showed that NPY/AgRP neurons but not POMC respond to the AMPK activator, 5-amino-1-β-D-ribofuranosyl-imidazole-4-carboxamide (AICAR), and increase intracellular Ca2+ levels. This study also showed that intracerebroventricular administration of AICAR increased food intake via AMPK activation of NPY neurons through Ca2+ influx, causing NPY-dependent food intake [72].

Taken together with the fact the POMC neurons do not contain any of the above mentioned, classical CBPs, such as Pv, Cb, Cr or Scgn, it is not surprising that the lack of a CaMKK-β, had little or no effect on POMC glucose or energy homeostasis. Li et al., (2010) showed that Ca2+ activates AMPK and oxygen free radicals also increase glucose uptake via glucose transporter GLUT4 in neurons [92], consistent with the idea that Ca2+ and ROS promote neuronal metabolism during negative energy balance when NPY/AgRP neurons are active and POMC neurons are silent. A recent study has also described an additional role of AMPK in mitophagy and mitochondrial biogenesis. Mihaylova et al., (2011) showed that activation of AMPK leads to the degradation of defective mitochondria and at the same time stimulates mitochondrial biogenesis [93]. Thus removing faulty mitochondria and generating new healthy mitochondria will to help combat cell stress by increasing energy production and decreasing mitochondrial oxidative stress. Nishihara et al., (2012) showed that, at least in the rostral ventrolateral medulla of the brainstem, ROS enhance glutamatergic excitatory input [94]. Two new studies showed that excitatory synaptic input in the Arc control NPY/AgRP containing neurons but not POMC [49, 95]. Putting these two findings together, we hypothesize that ROS may indirectly control feeding behavior, via increased glutamatergic input on NPY/AgRP neurons. Interestingly, deletion of NMDA receptors, a key route for Ca2+ to entry the cells, on NPY/AgRP neurons did not show any response to fasting. This finding suggests that Ca2+ signaling through NMDARs plays an important role to control energy homeostasis.

PHARMACOLOGICAL ASPECTS OF REDOX REGULATION IN THE FEEDING CIRCUIT OF THE BRAIN

The role of activated ionotropic glutamate receptors in Ca2+-induced oxidative stress in neurons was suggested almost 20 years ago, however the exact details of the mechanisms are still not completely understood. Increasing number of articles has been recently published showing that ionotropic glutamate receptors, such as the NMDA receptors, play a significant role in controlling the energy homeostasis and the maintenance of the cytosolic Ca2+ levels by forming a major Ca2+ entry system of the plasma membrane [29, 30]. NMDA receptors are responsible for cellular redox states and modified by either reduction, causing receptor potentiation, or oxidation, causing inhibition of receptor function [96]. Ligand binding initiates receptor opening by inducing conformational changes at the extracellular ligand-binding domain. The only redox modulation site on the NMDA receptors is a disulfide bond at the GluN1 subunit. Elimination of this bond by dithiothreitol potentiates the macroscopic current amplitude, increases the frequency and the duration of the channel opening [97-99]. Khan et al., (2004) showed that NMDA receptor activation in the lateral hypothalamus by acute microinjection of l–glutamate or other agonists plays a role in feeding [100]. Molecular and pharmacological inhibition of NMDA receptors in the hypothalamus is mediated by suppressed AMPK activity and lowers glucose production and increases feeding [101]. Several studies showed that AMPK in the hypothalamus regulates energy metabolism by integrating inputs from hormones, peptides, neurotransmitters, and nutrients [102-104]. It is highly likely that glutamate-induced neuronal excitation via NMDA receptors mediates the production of ROS. This event is accompanied by Ca2+ influx from the extracellular space, while Ca2+ is also released from the mitochondria. Due to an increase in the intracellular Ca2+ levels, cellular swelling occurs and cellular organelles take up Ca2+ to prevent further cell damage and death. However, the initial increase of ROS serves as a signal to prevent cell damage.

SUMMARY

Appetite is a complex behavior that involves homeostatic mechanisms driven by hypothalamic pathways. This review highlights that ROS levels, controlled by various ionic and fuel signals, play an important role in the hypothalamus. In both NPY and POMC neurons, ROS serve as useful markers in fuel sensing and utilization, but also byproducts of faulty mitochondrial respiration at high levels. Intracellular ROS levels directly control cellular activity of NPY/AgRP and POMC neuronal population and regulate food intake and body weight. At high levels that saturate buffering mechanisms, ROS may initiate cellular degeneration in either NPY/AgRP or POMC neurons and impair energy homeostasis. CBPs play a crucial role in Ca2+ buffering and preventing excessing ROS production. Although the exact function and expression of CBPs in hypothalamic neurons is unknown, we hypothesize that CBPs buffer Ca2+ and ROS in NPY/AgRP to maintain prolonged firing during negative energy balance.

Fig. (1).

Fig. (1)

NPY/AgRP and POMC/CART neurons are in close proximity as shown on the inset of Fig. (1)., however they produce opposing actions on food intake and body weight balance. Both ROS and CBPs may play important roles to mediate the differing actions on food intake and body weight balance. In satiety or during positive energy balance, POMC neurons are more active, using mostly glucose as their primary fuel. The increased cellular activity results in increased ROS production and this elevated ROS production also has an autoregulatory effect on POMC neurons, further increasing their activity. These cellular events act to suppress feeding behavior and decreasing further food intake. Under conditions of negative energy balance, such as fasting or calorie restrictions, NPY neurons become more active, using free fatty acids as their main fuel that results in feeding behavior. Secretagogin in NPY neurons potentially buffers excessive intracellular calcium and prevents ROS build up. Hormones in the blood stream, such as leptin and ghrelin, have the ability to increase the activity of POMC and NPY neurons, respectively. Once activated, NPY neurons send GABAergic, inhibitory synapsis directly to POMC neurons, to further strengthen the cellular pathways of food intake.

ACKNOWLEDGEMENTS

An Australia Fellowship awarded to George Paxinos (466028) and Australian Research Council Future Fellowship (FT100100966) and a project grant to Zane Andrews (1030037) by the National Health and Medical Research Council (NHMRC) supported this work.

ABBREVIATIONS

AgRP

 = agouti-related peptide

AICAR

 = 5-amino-1-β-D-ribofuranosyl-imidazole-4-carboxamide

AMPK

 = 5' AMP-activated protein kinase

Arc

 = arcuate hypothalamic nucleus

CaMKK

 = calmodulin-dependent protein kinase kinase

CART

 = cocaine and amphetamine related transcript

Cb

 = calbindin

CBP

 = calcium binding protein

Cr

 = calretinin

DM

 = dorsomedial hypothalamic nucleus

ETC

 = electron transfer chain

GPX

 = glutathione peroxidase

LepRb

 = leptin receptor

LH

 = lateral hypothalamic area

NMDA

 = N-Methyl-D-aspartate

NPY

 = neuropeptide-Y

Pa

 = paraventricular hypothalamic nucleus

PKC

 = protein kinase C

PMV

 = premammillary nucleus

POMC

 = pro-opiomelanocortin

PPA

 = phenylpropanolamine

Pv

 = parvalbumin

RNS

 = reactive nitrogen species

ROS

 = reactive oxygen species

Scgn

 = secretagogin

SCh

 = suprachiasmatic nucleus

SOD

 = superoxide dismutase

UCP2

 = uncoupling protein 2

VMH

 = ventromedial hypothalamic nucleus

CONFLICT OF INTEREST

The author(s) confirm that this article content has no conflict of interest.

REFERENCES

  • 1.Cheng X, Broberger C, Tong Y, Yongtao X, Ju G, Zhang X, Hokfelt T. Regulation of expression of neuropeptide Y Y1 and Y2 receptors in the arcuate nucleus of fasted rats. Brain Res. 1998;792(1 ):89–96. doi: 10.1016/s0006-8993(97)01468-6. [DOI] [PubMed] [Google Scholar]
  • 2.Krashes M J, Koda S, Ye C, Rogan S C, Adams A C, Cusher D S, Maratos-Flier E, Roth B L, Lowell B B. Rapid reversible activation of AgRP neurons drives feeding behavior in mice. J. Clin. Investig. 2011;121(4 ):1424–1428. doi: 10.1172/JCI46229. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Aponte Y, Atasoy D, Sternson S M. AGRP neurons are sufficient to orchestrate feeding behavior rapidly and without training. Nat. Neurosci. 2011;14(3 ):351–355. doi: 10.1038/nn.2739. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Vrang N, Larsen P J, Clausen J T, Kristensen P. Neurochemical characterization of hypothalamic cocaineamphetamine-regulated transcript neurons. J. Neurosci. 1999;19(10 ):RC5. doi: 10.1523/JNEUROSCI.19-10-j0006.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Vrang N, Tang-Christensen M, Larsen P J, Kristensen P. Recombinant CART peptide induces c-Fos expression in central areas involved in control of feeding behaviour. Brain Res. 1999;818(2 ):499–509. doi: 10.1016/s0006-8993(98)01349-3. [DOI] [PubMed] [Google Scholar]
  • 6.Horvath T L, Bechmann I, Naftolin F, Kalra S P, Leranth C. Heterogeneity in the neuropeptide Y-containing neurons of the rat arcuate nucleus: GABAergic and non-GABAergic subpopulations. Brain Res. 1997;756(1-2 ):283–286. doi: 10.1016/s0006-8993(97)00184-4. [DOI] [PubMed] [Google Scholar]
  • 7.Tong Q, Ye C P, Jones J E, Elmquist J K, Lowell B B. Synaptic release of GABA by AgRP neurons is required for normal regulation of energy balance. Nat .Neurosci. 2008;11(9 ):998–1000. doi: 10.1038/nn.2167. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Wu Q, Boyle M P, Palmiter R D. Loss of GABAergic signaling by AgRP neurons to the parabrachial nucleus leads to starvation. Cell. 2009;137(7 ):1225–1234. doi: 10.1016/j.cell.2009.04.022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Luquet S, Perez F A, Hnasko T S, Palmiter R D. NPY/AgRP neurons are essential for feeding in adult mice but can be ablated in neonates. Science. 2005;310(5748 ):683–685. doi: 10.1126/science.1115524. [DOI] [PubMed] [Google Scholar]
  • 10.Baldo B A, Daniel R A, Berridge C W, Kelley A E. Overlapping distributions of orexin/hypocretin- and dopamine-beta-hydroxylase immunoreactive fibers in rat brain regions mediating arousal, motivation, and stress. J. Comp. Neurol. 2003;464(2 ):220–237. doi: 10.1002/cne.10783. [DOI] [PubMed] [Google Scholar]
  • 11.Moga M M, Weis R P, Moore R Y. Efferent projections of the paraventricular thalamic nucleus in the rat. J. Comp. Neurol. 1995;359(2 ):221–238. doi: 10.1002/cne.903590204. [DOI] [PubMed] [Google Scholar]
  • 12.Larsen P J, Hay-Schmidt A, Mikkelsen J D. Efferent connections from the lateral hypothalamic region and the lateral preoptic area to the hypothalamic paraventricular nucleus of the rat. J. Comp. Neurol. 1994;342(2 ):299–319. doi: 10.1002/cne.903420211. [DOI] [PubMed] [Google Scholar]
  • 13.Dicken M S, Tooker R E, Hentges S T. Regulation of GABA and glutamate release from proopiomelanocortin neuron terminals in intact hypothalamic networks. J. Neurosci. 2012;32(12 ):4042–4048. doi: 10.1523/JNEUROSCI.6032-11.2012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Hentges S T, Otero-Corchon V, Pennock R L, King C M, Low M J. Proopiomelanocortin expression in both GABA and glutamate neurons. J. Neurosci. 2009;29(43 ):13684–13690. doi: 10.1523/JNEUROSCI.3770-09.2009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Atasoy D, Betley J N, Su H H, Sternson S M. Deconstruction of a neural circuit for hunger. Nature. 2012. [Epub ahead of print] [DOI] [PMC free article] [PubMed]
  • 16.Sies H, de Groot H. Role of reactive oxygen species in cell toxicity. Toxicol. Lett. 1992. pp. 64–65. Spec No, 547-551. [DOI] [PubMed]
  • 17.Miao L, St Clair D K. Regulation of superoxide dismutase genes: implications in disease. Free Radic Biol. Med. 2009;47(4 ):344–356. doi: 10.1016/j.freeradbiomed.2009.05.018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Liu X J, Yang W, Qi J S. [Oxidative stress and Alzheimer's disease] Sheng Li Xue Bao. 2012;64(1 ):87–95. [PubMed] [Google Scholar]
  • 19.Ramalingam M, Kim S J. Reactive oxygen/nitrogen species and their functional correlations in neurodegenerative diseases. J. Neural. Transm. 2012. [DOI] [PubMed]
  • 20.Choi D H, Cristovao A C, Guhathakurta S, Lee J, Joh T H, Beal M F, Kim Y S. NADPH Oxidase 1-Mediated Oxidative Stress Leads to Dopamine Neuron Death in Parkinson's Disease. Antioxid. Redox Signal. 2012. [Epub ahead of print] [DOI] [PMC free article] [PubMed]
  • 21.Li Q, Sato E F, Kira Y, Nishikawa M, Utsumi K, Inoue M. A possible cooperation of SOD1 and cytochrome c in mitochondria-dependent apoptosis. Free Radic Biol Med. 2006;40(1 ):173–181. doi: 10.1016/j.freeradbiomed.2005.09.037. [DOI] [PubMed] [Google Scholar]
  • 22.Gutowski N J, Pinkham J M, Akanmu D, Chirico S, Murphy R P. Free radicals in inflammatory neurological disease: increased lipid peroxidation and haptoglobin levels in Guillain Barre syndrome. Ir. J. Med. Sci. 1998;167(1 ):43–46. doi: 10.1007/BF02937555. [DOI] [PubMed] [Google Scholar]
  • 23.Choi D W. Glutamate neurotoxicity in cortical cell culture is calcium dependent. Neurosci. Lett. 1985;58(3 ):293–297. doi: 10.1016/0304-3940(85)90069-2. [DOI] [PubMed] [Google Scholar]
  • 24.Schanne F A, Kane A B, Young E E, Farber J L. Calcium dependence of toxic cell death: a final common pathway. Science. 1979;206(4419 ):700–702. doi: 10.1126/science.386513. [DOI] [PubMed] [Google Scholar]
  • 25.Strehler E E, Caride A J, Filoteo A G, Xiong Y, Penniston J T, Enyedi A. Plasma membrane Ca2+ ATPases as dynamic regulators of cellular calcium handling. Ann. N. Y. Acad. Sci. 2007;1099:226–236. doi: 10.1196/annals.1387.023. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Nicholls D G. Mitochondrial calcium function and dysfunction in the central nervous system. Biochim. Biophys. Acta. 2009;1787(11 ):1416–1424. doi: 10.1016/j.bbabio.2009.03.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.ressen C, Blumcke I, Celio M R. Calcium-binding proteins: selective markers of nerve cells. Cell Tissue Res. 1993;271(2 ):181–208. doi: 10.1007/BF00318606. [DOI] [PubMed] [Google Scholar]
  • 28.Weber A M, Wong F K, Tufford A R, Schlichter L C, Matveev V, Stanley E F. N-type Ca2+ channels carry the largest current: implications for nanodomains and transmitter release. Nat. Neurosci. 2010;13(11 ):1348–1350. doi: 10.1038/nn.2657. [DOI] [PubMed] [Google Scholar]
  • 29.Marques-da-Silva D, Gutierrez-Merino C. L-type voltage-operated calcium channels, N-methyl-D-aspartate receptors and neuronal nitric-oxide synthase form a calcium/redox nano-transducer within lipid rafts. Biochem. Biophys. Res. Commun. 2012;420(2 ):257–262. doi: 10.1016/j.bbrc.2012.02.145. [DOI] [PubMed] [Google Scholar]
  • 30.Gutierrez-Martin Y, Martin-Romero F J, Henao F, Gutierrez-Merino C. Alteration of cytosolic free calcium homeostasis by SIN-1: high sensitivity of L-type Ca2+ channels to extracellular oxidative/nitrosative stress in cerebellar granule cells. J. Neurochem. 2005;92(4 ):973–989. doi: 10.1111/j.1471-4159.2004.02964.x. [DOI] [PubMed] [Google Scholar]
  • 31.Leloup C, Magnan C, Benani A, Bonnet E, Alquier T, Offer G, Carriere A, Periquet A, Fernandez Y, Ktorza A, Casteilla L, Penicaud L. Mitochondrial reactive oxygen species are required for hypothalamic glucose sensing. Diabetes. 2006;55(7 ):2084–2090. doi: 10.2337/db06-0086. [DOI] [PubMed] [Google Scholar]
  • 32.Benani A, Troy S, Carmona M C, Fioramonti X, Lorsignol A, Leloup C, Casteilla L, Penicaud L. Role for mitochondrial reactive oxygen species in brain lipid sensing: redox regulation of food intake. Diabetes. 2007;56(1 ):152–160. doi: 10.2337/db06-0440. [DOI] [PubMed] [Google Scholar]
  • 33.Thorens B. Glucose sensing and the pathogenesis of obesity and type 2 diabetes. Int. J. Obes (Lond) 2008;32 (Suppl 6 ):S62–71. doi: 10.1038/ijo.2008.208. [DOI] [PubMed] [Google Scholar]
  • 34.rews Z B, Liu Z W, Walllingford N, Erion D M, Borok E, Friedman J M, Tschop M H, Shanabrough M, Cline G, Shulman G I, Coppola A, Gao X B, Horvath T L, Diano S. UCP2 mediates ghrelin's action on NPY/AgRP neurons by lowering free radicals. Nature. 2008;454(7206 ):846–851. doi: 10.1038/nature07181. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Ibrahim N, Bosch M A, Smart J L, Qiu J, Rubinstein M, Ronnekleiv O K, Low M J, Kelly M J. Hypothalamic proopiomelanocortin neurons are glucose responsive and express K(ATP) channels. Endocrinology. 2003;144(4 ):1331–1340. doi: 10.1210/en.2002-221033. [DOI] [PubMed] [Google Scholar]
  • 36.Mountjoy P D, Bailey S J, Rutter G A. Inhibition by glucose or leptin of hypothalamic neurons expressing neuropeptide Y requires changes in AMP-activated protein kinase activity. Diabetologia. 2007;50(1 ):168–177. doi: 10.1007/s00125-006-0473-3. [DOI] [PubMed] [Google Scholar]
  • 37.Hernandez-Fonseca K, Cardenas-Rodriguez N, Pedraza-Chaverri J, Massieu L. Calcium-dependent production of reactive oxygen species is involved in neuronal damage induced during glycolysis inhibition in cultured hippocampal neurons. J. Neurosci. Res. 2008;86(8 ):1768–1780. doi: 10.1002/jnr.21634. [DOI] [PubMed] [Google Scholar]
  • 38.Kuo D Y, Chen P N, Chu S C, Hsieh Y S. Knocking down the transcript of NF-kappaB modulates the reciprocal regulation of endogenous antioxidants and feeding behavior in phenylpropanolamine-treated rats. Arch. Toxicol. 2012;86(3 ):453–463. doi: 10.1007/s00204-011-0761-7. [DOI] [PubMed] [Google Scholar]
  • 39.Cheng J T, Kuo D Y. Both alpha1-adrenergic and D(1)-dopaminergic neurotransmissions are involved in phenylpropanolamine-mediated feeding suppression in mice. Neurosci. Lett. 2003;347(2 ):136–138. doi: 10.1016/s0304-3940(03)00637-2. [DOI] [PubMed] [Google Scholar]
  • 40.Carneiro P, Duarte M, Videira A. Disruption of alternative NAD(P)H dehydrogenases leads to decreased mitochondrial ROS in Neurospora crassa. Free Radic. Biol. Med. 2012;52(2 ):402–409. doi: 10.1016/j.freeradbiomed.2011.10.492. [DOI] [PubMed] [Google Scholar]
  • 41.Horvath T L, rews Z B, Diano S. Fuel utilization by hypothalamic neurons: roles for ROS. Trends Endocrinol. Metab. 2009;20(2 ):78–87. doi: 10.1016/j.tem.2008.10.003. [DOI] [PubMed] [Google Scholar]
  • 42.Kuo D Y, Chen P N, Yang S F, Chu S C, Chen C H, Kuo M H, Yu C H, Hsieh Y S. Role of reactive oxygen species-related enzymes in neuropeptide y and proopiomelanocortin-mediated appetite control: a study using atypical protein kinase C knockdown. Antioxid. Redox Signal. 2011;15(8 ):2147–2159. doi: 10.1089/ars.2010.3738. [DOI] [PubMed] [Google Scholar]
  • 43.Barja G. Mitochondrial oxygen radical generation and leak: sites of production in states 4 and 3, organ specificity, and relation to aging and longevity. J Bioenerg. Biomembr. 1999;31(4 ):347–366. doi: 10.1023/a:1005427919188. [DOI] [PubMed] [Google Scholar]
  • 44.Chen C H, Chern C L, Lin C C, Lu F J, Shih M K, Hsieh P Y, Liu T Z. Involvement of reactive oxygen species, but not mitochondrial permeability transition in the apoptotic induction of human SK-Hep-1 hepatoma cells by shikonin. Planta Med. 2003;69(12 ):1119–1124. doi: 10.1055/s-2003-45193. [DOI] [PubMed] [Google Scholar]
  • 45.Maltais L J, Lane P W, Beamer W G. Anorexia a recessive mutation causing starvation in preweanling mice. J. Hered. 1984;75(6 ):468–472. doi: 10.1093/oxfordjournals.jhered.a109987. [DOI] [PubMed] [Google Scholar]
  • 46.Lindfors C, Nilsson I A, Garcia-Roves P M, Zuberi A R, Karimi M, Donahue L R, Roopenian D C, Mulder J, Uhlen M, Ekstrom T J, Davisson M T, Hokfelt T G, Schalling M, Johansen J E. Hypothalamic mitochondrial dysfunction associated with anorexia in the anx/anx mouse. Proc. Natl. Acad. Sci. U. S. A. 2011;108(44 ):18108–18113. doi: 10.1073/pnas.1114863108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Diano S, Liu Z W, Jeong J K, Dietrich M O, Ruan H B, Kim E, Suyama S, Kelly K, Gyengesi E, Arbiser J L, Belsham D D, Sarruf D A, Schwartz M W, Bennett A M, Shanabrough M, Mobbs C V, Yang X, Gao X B, Horvath T L. Peroxisome proliferation-associated control of reactive oxygen species sets melanocortin tone and feeding in diet-induced obesity. Nat. Med. 2011;17(9 ):1121–1127. doi: 10.1038/nm.2421. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes. 2005;54(6 ):1615–1625. doi: 10.2337/diabetes.54.6.1615. [DOI] [PubMed] [Google Scholar]
  • 49.Yang Y, Atasoy D, Su H H, Sternson S M. Hunger states switch a flip-flop memory circuit via a synaptic AMPK-dependent positive feedback loop. Cell. 2011;146(6 ):992–1003. doi: 10.1016/j.cell.2011.07.039. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Lage R, Vazquez M J, Varela L, Saha A K, Vidal-Puig A, Nogueiras R, Dieguez C, Lopez M. Ghrelin effects on neuropeptides in the rat hypothalamus depend on fatty acid metabolism actions on BSX but not on gender. FASEB J. 2010;24(8 ):2670–2679. doi: 10.1096/fj.09-150672. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.rews Z B. Central mechanisms involved in the orexigenic actions of ghrelin. Peptides. 2011;32(11 ):2248–2255. doi: 10.1016/j.peptides.2011.05.014. [DOI] [PubMed] [Google Scholar]
  • 52.Brand M D. Uncoupling to survive? The role of mitochondrial inefficiency in ageing. Exp. Gerontol. 2000;35(6-7 ):811–820. doi: 10.1016/s0531-5565(00)00135-2. [DOI] [PubMed] [Google Scholar]
  • 53.rews Z B, Horvath T L. Uncoupling protein-2 regulates lifespan in mice. Am. J. Physiol. Endocrinol. Metab. 2009;296(4 ):E621–627. doi: 10.1152/ajpendo.90903.2008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Patterson C M, Leshan R L, Jones J C, Myers M G Jr. Molecular mapping of mouse brain regions innervated by leptin receptor-expressing cells. Brain Res. 2011;1378:18–28. doi: 10.1016/j.brainres.2011.01.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Qiu J, Fang Y, Ronnekleiv O K, Kelly M J. Leptin excites proopiomelanocortin neurons via activation of TRPC channels. J. Neurosci. 2010;30(4 ):1560–1565. doi: 10.1523/JNEUROSCI.4816-09.2010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Chinopoulos C, Connor J A, Shuttleworth C W. Emergence of a spermine-sensitive, non-inactivating conductance in mature hippocampal CA1 pyramidal neurons upon reduction of extracellular Ca2+: dependence on intracellular Mg2+ and ATP. Neuroche. Int. 2007;50(1 ):148–158. doi: 10.1016/j.neuint.2006.07.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Weber J T. Altered calcium signaling following traumatic brain injury. Front. Pharmacol. 2012;3:60. doi: 10.3389/fphar.2012.00060. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Miller R J. The control of neuronal Ca2+ homeostasis. Prog. Neurobiol. 1991;37(3 ):255–285. doi: 10.1016/0301-0082(91)90028-y. [DOI] [PubMed] [Google Scholar]
  • 59.Loew L M, Carrington W, Tuft R A, Fay F S. Physiological cytosolic Ca2+ transients evoke concurrent mitochondrial depolarizations. Proc. Natl. Acad. Sci. U. S. A. 1994;91(26 ):12579–12583. doi: 10.1073/pnas.91.26.12579. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Schinder A F, Olson E C, Spitzer N C, Montal M. Mitochondrial dysfunction is a primary event in glutamate neurotoxicity. J. Neurosci. 1996;16(19 ):6125–6133. doi: 10.1523/JNEUROSCI.16-19-06125.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Fleury C, Mignotte B, Vayssiere J L. Mitochondrial reactive oxygen species in cell death signaling. Biochimie. 2002;84(2-3 ):131–141. doi: 10.1016/s0300-9084(02)01369-x. [DOI] [PubMed] [Google Scholar]
  • 62.Hawley S A, Pan D A, Mustard K J, Ross L, Bain J, Edelman A M, Frenguelli B G, Hardie D G. Calmodulin-dependent protein kinase kinase-beta is an alternative upstream kinase for AMP-activated protein kinase. Cell Metab. 2005;2(1 ):9–19. doi: 10.1016/j.cmet.2005.05.009. [DOI] [PubMed] [Google Scholar]
  • 63.Hurley R L, erson K A, Franzone J M, Kemp B E, Means A R, Witters L A. The Ca2+/calmodulin-dependent protein kinase kinases are AMP-activated protein kinase kinases. J. Biol. Chem. 2005;280(32 ):29060–29066. doi: 10.1074/jbc.M503824200. [DOI] [PubMed] [Google Scholar]
  • 64.Woods A, Dickerson K, Heath R, Hong S P, Momcilovic M, Johnstone S R, Carlson M, Carling D. Ca2+/calmodulin-dependent protein kinase kinase-beta acts upstream of AMP-activated protein kinase in mammalian cells. Cell Metab. 2005;2(1 ):21–33. doi: 10.1016/j.cmet.2005.06.005. [DOI] [PubMed] [Google Scholar]
  • 65.erson K A, Ribar T J, Lin F, Noeldner P K, Green M F, Muehlbauer M J, Witters L A, Kemp B E, Means A R. Hypothalamic CaMKK2 contributes to the regulation of energy balance. Cell Metab. 2008;7(5 ):377–388. doi: 10.1016/j.cmet.2008.02.011. [DOI] [PubMed] [Google Scholar]
  • 66.McCullough L A, Westfall T C. Mechanism of catecholamine synthesis inhibition by neuropeptide Y: role of Ca2+ channels and protein kinases. J. Neurochem. 1996;67(3 ):1090–1099. doi: 10.1046/j.1471-4159.1996.67031090.x. [DOI] [PubMed] [Google Scholar]
  • 67.Cummings D E, Overduin J, Shannon M H, Foster-Schubert K E. Hormonal mechanisms of weight loss and diabetes resolution after bariatric surgery. Surg. Obes. Relat. Dis. 2005;1(3 ):358–368. doi: 10.1016/j.soard.2005.03.208. [DOI] [PubMed] [Google Scholar]
  • 68.Oakhill J S, Steel R, Chen Z P, Scott J W, Ling N, Tam S, Kemp B E. AMPK is a direct adenylate charge-regulated protein kinase. Science. 2011;332(6036 ):1433–1435. doi: 10.1126/science.1200094. [DOI] [PubMed] [Google Scholar]
  • 69.Carling D. The role of the AMP-activated protein kinase in the regulation of energy homeostasis. Novartis Found Symp. 2007;286:72–81. doi: 10.1002/9780470985571.ch7. discussion 81-75, 162-163, 196-203. [DOI] [PubMed] [Google Scholar]
  • 70.Gido G, Katsura K, Kristian T, Siesjo B K. Influence of plasma glucose concentration on rat brain extracellular calcium transients during spreading depression. J. Cereb. Blood Flow Metab. 1993;13(1 ):179–182. doi: 10.1038/jcbfm.1993.21. [DOI] [PubMed] [Google Scholar]
  • 71.Kohno D, Sone H, Minokoshi Y, Yada T. Ghrelin raises [Ca2+]i via AMPK in hypothalamic arcuate nucleus NPY neurons. Biochem Biophys. Res. Commun. 2008;366(2 ):388–392. doi: 10.1016/j.bbrc.2007.11.166. [DOI] [PubMed] [Google Scholar]
  • 72.Kohno D, Sone H, Tanaka S, Kurita H, Gantulga D, Yada T. AMP-activated protein kinase activates neuropeptide Y neurons in the hypothalamic arcuate nucleus to increase food intake in rats. Neurosci. Lett. 2011;499(3 ):194–198. doi: 10.1016/j.neulet.2011.05.060. [DOI] [PubMed] [Google Scholar]
  • 73.Celio M R. Calbindin D-28k and parvalbumin in the rat nervous system. Neuroscience. 1990;35(2 ):375–475. doi: 10.1016/0306-4522(90)90091-h. [DOI] [PubMed] [Google Scholar]
  • 74.Meszar Z, Girard F, Saper C B, Celio M R. The lateral hypothalamic parvalbumin-immunoreactive (PV1) nucleus in rodents. J. Comp. Neurol. 2012;520(4 ):798–815. doi: 10.1002/cne.22789. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Loikkanen J J, Naarala J, Savolainen K M. Modification of glutamate-induced oxidative stress by lead: the role of extracellular calcium. Free Radic. Biol. Med. 1998;24(2 ):377–384. doi: 10.1016/s0891-5849(97)00219-0. [DOI] [PubMed] [Google Scholar]
  • 76.Coyle J T, Puttfarcken P. Oxidative stress, glutamate, and neurodegenerative disorders. Science. 1993;262(5134 ):689–695. doi: 10.1126/science.7901908. [DOI] [PubMed] [Google Scholar]
  • 77.Schoepp D D. Novel functions for subtypes of metabotropic glutamate receptors. Neurochem. Int. 1994;24(5 ):439–449. doi: 10.1016/0197-0186(94)90092-2. [DOI] [PubMed] [Google Scholar]
  • 78.Sotonyi P, Gao Q, Bechmann I, Horvath T L. Estrogen promotes parvalbumin expression in arcuate nucleus POMC neurons. Reprod. Sci. 2010;17(12 ):1077–1080. doi: 10.1177/1933719110379651. [DOI] [PubMed] [Google Scholar]
  • 79.Wagner L, Oliyarnyk O, Gartner W, Nowotny P, Groeger M, Kaserer K, Waldhausl W, Pasternack M S. Cloning and expression of secretagogin, a novel neuroendocrine- and pancreatic islet of Langerhans-specific Ca2+-binding protein. J. Biol. Chem. 2000;275(32 ):24740–24751. doi: 10.1074/jbc.M001974200. [DOI] [PubMed] [Google Scholar]
  • 80.Alpar A, Attems J, Mulder J, Hokfelt T, Harkany T. The renaissance of Ca2+-binding proteins in the nervous system: secretagogin takes center stage. Cell Signal. 2012;24(2 ):378–387. doi: 10.1016/j.cellsig.2011.09.028. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81.Mulder J, Spence L, Tortoriello G, Dinieri J A, Uhlen M, Shui B, Kotlikoff M I, Yanagawa Y, Aujard F, Hokfelt T, Hurd Y L, Harkany T. Secretagogin is a Ca2+-binding protein identifying prospective extended amygdala neurons in the developing mammalian telencephalon. Eur. J. Neurosci. 2010;31(12 ):2166–2177. doi: 10.1111/j.1460-9568.2010.07275.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82.Mulder J, Zilberter M, Spence L, Tortoriello G, Uhlen M, Yanagawa Y, Aujard F, Hokfelt T, Harkany T. Secretagogin is a Ca2+-binding protein specifying subpopulations of telencephalic neurons. Proc. Natl. Acad. Sci. U. S. A. 2009;106(52 ):22492–22497. doi: 10.1073/pnas.0912484106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83.Kohno D, Gao H Z, Muroya S, Kikuyama S, Yada T. Ghrelin directly interacts with neuropeptide-Y-containing neurons in the rat arcuate nucleus: Ca2+ signaling via protein kinase A and N-type channel-dependent mechanisms and cross-talk with leptin and orexin. Diabetes. 2003;52(4 ):948–956. doi: 10.2337/diabetes.52.4.948. [DOI] [PubMed] [Google Scholar]
  • 84.Cavalcante J S, Britto L R, Toledo C A, Nascimento E S Jr, Lima R R, Pontes A L, Costa M S. Calcium-binding proteins in the circadian centers of the common marmoset (Callithrix jacchus) and the rock cavy (Kerodon rupestris) brains. Brain Res. Bull. 2008;76(4 ):354–360. doi: 10.1016/j.brainresbull.2008.02.028. [DOI] [PubMed] [Google Scholar]
  • 85.Ikeda M, Allen C N. Developmental changes in calbindin-D28k and calretinin expression in the mouse suprachiasmatic nucleus. Eur. J. Neurosci. 2003;17(5 ):1111–1118. doi: 10.1046/j.1460-9568.2003.02515.x. [DOI] [PubMed] [Google Scholar]
  • 86.Watson C a P G. Chemoarchitectonic Atlas of the Mouse Brain. Elsevier. 2010.
  • 87.Kahn B B, Alquier T, Carling D, Hardie D G. AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab. 2005;1(1 ):15–25. doi: 10.1016/j.cmet.2004.12.003. [DOI] [PubMed] [Google Scholar]
  • 88.Brandon A E, Hoy A J, Wright L E, Turner N, Hegarty B D, Iseli T J, Julia Xu X, Cooney G J, Saha A K, Ruderman N B, Kraegen E W. The evolution of insulin resistance in muscle of the glucose infused rat. Arch. Biochem. Biophys. 2011;509(2 ):133–141. doi: 10.1016/j.abb.2011.03.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 89.Claret M, Smith M A, Knauf C, Al-Qassab H, Woods A, Heslegrave A, Piipari K, Emmanuel J J, Colom A, Valet P, Cani P D, Begum G, White A, Mucket P, Peters M, Mizuno K, Batterham R L, Giese K P, Ashworth A, Burcelin R, Ashford M L, Carling D, Withers D J. Deletion of Lkb1 in pro-opiomelanocortin neurons impairs peripheral glucose homeostasis in mice. Diabetes. 2011;60(3 ):735–745. doi: 10.2337/db10-1055. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 90.Simmgen M, Knauf C, Lopez M, Choudhury A I, Charalambous M, Cantley J, Bedford D C, Claret M, Iglesias M A, Heffron H, Cani P D, Vidal-Puig A, Burcelin R, Withers D J. Liver-specific deletion of insulin receptor substrate 2 does not impair hepatic glucose and lipid metabolism in mice. Diabetologia. 2006;49(3 ):552–561. doi: 10.1007/s00125-005-0084-4. [DOI] [PubMed] [Google Scholar]
  • 91.Racioppi L, Noeldner P K, Lin F, Arvai S, Means A R. Calcium/Calmodulin-dependent Protein Kinase Kinase 2 Regulates Macrophage-mediated Inflammatory Responses. J. Biol. Chem. 2012;287(14 ):11579–11591. doi: 10.1074/jbc.M111.336032. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 92.Li M, Zhao J, Hu Y, Lu H, Guo J. Oxygen free radicals regulate energy metabolism via AMPK pathway following cerebral ischemia. Neurol. Res. 2010;32(7 ):779–784. doi: 10.1179/174313209X459174. [DOI] [PubMed] [Google Scholar]
  • 93.Mihaylova M M, Shaw R J. The AMPK signalling pathway coordinates cell growth, autophagy and metabolism. Nat. Cell Biol. 2011;13(9 ):1016–1023. doi: 10.1038/ncb2329. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 94.Nishihara M, Hirooka Y, Matsukawa R, Kishi T, Sunagawa K. Oxidative stress in the rostral ventrolateral medulla modulates excitatory and inhibitory inputs in spontaneously hypertensive rats. J. Hypertens. 2012;30(1 ):97–106. doi: 10.1097/HJH.0b013e32834e1df4. [DOI] [PubMed] [Google Scholar]
  • 95.Liu T, Kong D, Shah B P, Ye C, Koda S, Saunders A, Ding J B, Yang Z, Sabatini B L, Lowell B B. Fasting Activation of AgRP Neurons Requires NMDA Receptors and Involves Spinogenesis and Increased Excitatory Tone. Neuron. 2012;73(3 ):511–522. doi: 10.1016/j.neuron.2011.11.027. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 96.Aizenman E. Modulation of N-methyl-D-aspartate receptors by hydroxyl radicals in rat cortical neurons in vitro. Neurosci. Lett. 1995;189(1 ):57–59. doi: 10.1016/0304-3940(95)11442-y. [DOI] [PubMed] [Google Scholar]
  • 97.Talukder I, Kazi R, Wollmuth L P. GluN1-specific redox effects on the kinetic mechanism of NMDA receptor activation. Biophys. J. 2011;101(10 ):2389–2398. doi: 10.1016/j.bpj.2011.10.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 98.Talukder I, Wollmuth L P. Local constraints in either the GluN1 or GluN2 subunit equally impair NMDA receptor pore opening. J. Gen. Physiol. 2011;138(2 ):179–194. doi: 10.1085/jgp.201110623. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 99.Kohr G, Eckardt S, Luddens H, Monyer H, Seeburg P H. NMDA receptor channels: subunit-specific potentiation by reducing agents. Neuron. 1994;12(5 ):1031–1040. doi: 10.1016/0896-6273(94)90311-5. [DOI] [PubMed] [Google Scholar]
  • 100.Khan A M, Cheung H H, Gillard E R, Palarca J A, Welsbie D S, Gurd J W, Stanley B G. Lateral hypothalamic signaling mechanisms underlying feeding stimulation: differential contributions of Src family tyrosine kinases to feeding triggered either by NMDA injection or by food deprivation. J. Neurosci. 2004;24(47 ):10603–10615. doi: 10.1523/JNEUROSCI.3390-04.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 101.Lam C K, Chari M, Rutter G A, Lam T K. Hypothalamic nutrient sensing activates a forebrain-hindbrain neuronal circuit to regulate glucose production in vivo. Diabetes. 2011;60(1 ):107–113. doi: 10.2337/db10-0994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 102.Minokoshi Y, Shiuchi T, Lee S, Suzuki A, Okamoto S. Role of hypothalamic AMP-kinase in food intake regulation. Nutrition. 2008;24(9 ):786–790. doi: 10.1016/j.nut.2008.06.002. [DOI] [PubMed] [Google Scholar]
  • 103.Ramamurthy S, Ronnett G V. Developing a head for energy sensing: AMP-activated protein kinase as a multifunctional metabolic sensor in the brain. J. Physiol. 2006;574(Pt 1 ):85–93. doi: 10.1113/jphysiol.2006.110122. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 104.Minokoshi Y, Alquier T, Furukawa N, Kim Y B, Lee A, Xue B, Mu J, Foufelle F, Ferre P, Birnbaum M J, Stuck B J, Kahn B B. AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus. Nature. 2004;428(6982 ):569–574. doi: 10.1038/nature02440. [DOI] [PubMed] [Google Scholar]

Articles from Current Neuropharmacology are provided here courtesy of Bentham Science Publishers

RESOURCES